These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32117705)

  • 61. The ceRNA PVT1 inhibits proliferation of ccRCC cells by sponging miR-328-3p to elevate FAM193B expression.
    Xie G; Zheng X; Zheng Z; Wu R; Yao Z; Huang W; Sun F; Mu X; Wu K; Zheng J
    Aging (Albany NY); 2021 Sep; 13(17):21712-21728. PubMed ID: 34518442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
    Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
    J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Construction of a novel ceRNA network and identification of lncRNA
    Wang S; Li XC; Zhu JR; Ma ZJ; Ran JT; Zhou YN
    Transl Cancer Res; 2021 Feb; 10(2):938-952. PubMed ID: 35116422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies.
    Houshmand M; Yazdi N; Kazemi A; Atashi A; Hamidieh AA; Anjam Najemdini A; Mohammadi Pour M; Nikougoftar Zarif M
    Int J Biochem Cell Biol; 2018 May; 98():54-64. PubMed ID: 29510227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.
    Zhu S; Shuai P; Yang C; Zhang Y; Zhong S; Liu X; Chen K; Ran Q; Yang H; Zhou Y
    Oncotarget; 2017 Dec; 8(68):113174-113184. PubMed ID: 29348896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma.
    Yang L; Peng X; Jin H; Liu J
    Gene; 2019 May; 697():94-102. PubMed ID: 30794914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
    Zeng C; Yu X; Lai J; Yang L; Chen S; Li Y
    J Hematol Oncol; 2015 Nov; 8():126. PubMed ID: 26545364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an
    Morea A; Saravi S; Sisu C; Hall M; Tosi S; Karteris E; Storlazzi CT
    Anticancer Res; 2024 May; 44(5):1817-1827. PubMed ID: 38677725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.
    Zhang Y; Dang YW; Wang X; Yang X; Zhang R; Lv ZL; Chen G
    Am J Transl Res; 2017; 9(9):3904-3917. PubMed ID: 28979669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer.
    Chang Z; Cui J; Song Y
    Gene; 2018 May; 654():36-42. PubMed ID: 29452232
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells.
    You L; Chang D; Du HZ; Zhao YP
    Biochem Biophys Res Commun; 2011 Apr; 407(1):1-6. PubMed ID: 21316338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.
    Zhao S; Fan NF; Chen XH; Zhuo CH; Xu CW; Lin RB
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4173-4184. PubMed ID: 31173288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long noncoding RNA Pvt1 promotes the proliferation and migration of Schwann cells by sponging microRNA-214 and targeting c-Jun following peripheral nerve injury.
    Pan B; Guo D; Jing L; Li K; Li X; Li G; Gao X; Li ZW; Zhao W; Feng H; Cao MH
    Neural Regen Res; 2023 May; 18(5):1147-1153. PubMed ID: 36255005
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.
    Ghetti M; Vannini I; Storlazzi CT; Martinelli G; Simonetti G
    Mol Cancer; 2020 Mar; 19(1):69. PubMed ID: 32228602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bioinformatics analysis of lncRNA-related ceRNA networks in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang.
    Wang Y; Gao J; Zhang L; Yang R; Zhang Y; Shan L; Li X; Ma K
    Front Cardiovasc Med; 2023; 10():1155767. PubMed ID: 37396592
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation.
    Zheng C; Xiao Y; Li Y; He D
    Oncol Lett; 2019 Aug; 18(2):1225-1234. PubMed ID: 31423183
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214.
    Chen Y; Du H; Bao L; Liu W
    Cancer Biol Med; 2018 Aug; 15(3):238-250. PubMed ID: 30197791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    Yu C; Longfei L; Long W; Feng Z; Chen J; Chao L; Peihua L; Xiongbing Z; Hequn C
    J Cell Physiol; 2019 Feb; 234(2):1346-1353. PubMed ID: 30076714
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.